Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide

被引:230
作者
Thomsen, Henrik S. [1 ]
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Diagnost Radiol, DK-2730 Herlev, Denmark
关键词
D O I
10.1007/s00330-006-0495-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:2619 / 2621
页数:3
相关论文
共 10 条
[1]  
BehraMiellet J, 1996, METHOD FIND EXP CLIN, V18, P437
[2]  
COWPER SE, 2001, NEPHROGENIC FIBROSIN
[3]   Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure [J].
Evenepoel, P ;
Zeegers, M ;
Segaert, S ;
Claes, K ;
Kuypers, D ;
Maes, B ;
Flamen, P ;
Fransis, S ;
Vanrenterghem, Y .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (02) :469-473
[4]  
FLATEN H, 2006, DEAR HEALTHCARE PROF
[5]  
*FOOD DRUG ADM, 2006, PUBL HLTH ADV GAD CO
[7]   Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? [J].
Grobner, T .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) :1104-1108
[8]   Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging [J].
Marckmann, Peter ;
Skov, Lone ;
Rossen, Kristian ;
Dupont, Anders ;
Damholt, Mette Brimnes ;
Heaf, James Goya ;
Thomsen, Henrik S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2359-2362
[9]   Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature [J].
Mendoza, FA ;
Artlett, CM ;
Sandorfi, N ;
Latinis, K ;
Piera-Velazquez, S ;
Jimenez, SA .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2006, 35 (04) :238-249
[10]  
Thomsen HS, 2006, CONTRAST MEDIA SAFET